LARIMAR THERAPEUTICS, INC. Current Assets
LARIMAR THERAPEUTICS, INC. (LRMR) had Current Assets of $160.67 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $160.67M.
- 2026-03-31: Assets, Current $204.98M.
- 2025-12-31: Assets, Current $142.02M.
- 2025-09-30: Assets, Current $183.22M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $160.67M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $204.98M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $142.02M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $183.22M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $145.56M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $165.49M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $195.30M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $213.26M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $231.13M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $230.95M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $90.17M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $98.48M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $106.48M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $113.46M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $120.74M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $127.13M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $56.74M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $64.88M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $72.20M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $81.25M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $74.04M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $86.13M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $97.95M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $107.82M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $119.11M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $64.68M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.75M 10-K · filed 2021-03-04 | $71.50M 10-K · filed 2020-03-05 |
| 2019-09-30 | $83.44M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $94.00M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $107.47M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $121.33M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $131.47M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $78.03M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $91.42M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $104.92M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $95.66M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $107.97M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $118.68M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $130.90M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $141.57M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $153.15M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $168.84M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $188.11M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $206.09M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $221.63M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $236.33M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $117.20M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $129.47M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $136.82M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $37.36M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |